King’s led Multiple Sclerosis fatigue app part of government’s £10M medtech investment
A digital therapy developed by researchers at King’s College London and Avegen, is one of eight innovative technologies to receive support from the government with the aim to accelerate the pathway for NHS and/or market approval.
By NIHR Maudsley BRC at 21 Feb 2024